PTSD Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People of any gender, race, or ethnicity between 18 and 70 years old
- People who speak English
- People who have been diagnosed with Opioid Use Disorder (OUD) — a condition involving dependence on opioids — according to standard diagnostic guidelines (DSM-5)
- People who have been diagnosed with PTSD (Post-Traumatic Stress Disorder) according to standard diagnostic guidelines (DSM-5), and who have some memory of the traumatic event that led to their PTSD
- People who have been on a steady, unchanged dose of medication for Opioid Use Disorder for at least one month
- People taking medications for mental health who have been on a steady, unchanged dose of those medications for at least one month before the study begins
Who may not be able to join:
- People with certain unmanaged psychiatric conditions, such as uncontrolled psychosis, mania, or bipolar disorder
- People who are considered an immediate risk to themselves, including those with current thoughts of suicide and a specific plan, or those showing other high-risk behaviours (such as refusing medication for OUD or engaging in risky fentanyl use), as assessed by the research team
- People who meet the diagnostic criteria for another substance use disorder (not involving opioids) and who consider that other substance to be their primary substance of use
- People who are currently receiving an ongoing, structured talking therapy specifically for substance use disorders or PTSD outside of their standard treatment programme
- People with serious medical conditions needing urgent and intensive treatment, such as unstable or advanced liver disease
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Tanya Saraiya, PhD, Medical University of South Carolina
Phone: 8438762374
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in Opioid Use; Change in Posttraumatic Stress Disorder Symptoms
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.